| Lung Cancer Treatments and Mutations | Lifetime | 34 | JP 2 | 99.90 |
| Lung Cancer Diagnosis and Treatment | Lifetime | 70 | JP 3 | 99.72 |
| Lung Cancer Research Studies | Lifetime | 51 | JP 3 | 99.74 |
| Cancer Genomics and Diagnostics | Lifetime | 123 | JP 1 | 99.71 |
| Medical Imaging and Pathology Studies | Lifetime | 77 | JP 4 | 99.36 |
| Colorectal Cancer Treatments and Studies | Lifetime | 101 | JP 8 | 99.60 |
| RNA modifications and cancer | Lifetime | 283 | JP 9 | 99.32 |
| Lymphoma Diagnosis and Treatment | Lifetime | 511 | JP 11 | 98.70 |
| Genetic factors in colorectal cancer | Lifetime | 387 | JP 20 | 98.56 |
| HER2/EGFR in Cancer Research | Lifetime | 340 | JP 12 | 98.54 |
| Gastric Cancer Management and Outcomes | Lifetime | 977 | JP 205 | 98.18 |
| Neuroendocrine Tumor Research Advances | Lifetime | 587 | JP 43 | 98.05 |
| Pancreatic and Hepatic Oncology Research | Lifetime | 983 | JP 140 | 97.98 |
| Cancer Cells and Metastasis | Lifetime | 660 | JP 33 | 97.34 |
| Cancer Diagnosis and Treatment | Lifetime | 593 | JP 22 | 97.16 |
| Cancer-related gene regulation | Lifetime | 636 | JP 65 | 97.09 |
| Viral-associated cancers and disorders | Lifetime | 547 | JP 19 | 97.22 |
| Gastrointestinal Tumor Research and Treatment | Lifetime | 865 | JP 248 | 96.03 |
| Salivary Gland Tumors Diagnosis and Treatment | Lifetime | 762 | JP 43 | 95.79 |
| PI3K/AKT/mTOR signaling in cancer | Lifetime | 928 | JP 43 | 93.68 |
| Lung Cancer Diagnosis and Treatment | 2021-2025 | 49 | JP 4 | 99.25 |
| Cancer Genomics and Diagnostics | 2021-2025 | 118 | JP 4 | 99.03 |
| Lung Cancer Treatments and Mutations | 2021-2025 | 103 | JP 8 | 99.33 |
| Lung Cancer Research Studies | 2021-2025 | 268 | JP 14 | 96.68 |
| Genetic factors in colorectal cancer | 2021-2025 | 394 | JP 22 | 92.96 |
| Colorectal Cancer Treatments and Studies | 2021-2025 | 792 | JP 89 | 90.81 |
| Medical Imaging and Pathology Studies | 2021-2025 | 287 | JP 21 | 86.86 |
| Sarcoma Diagnosis and Treatment | 2021-2025 | 668 | JP 54 | 89.85 |
| Neuroendocrine Tumor Research Advances | 2021-2025 | 914 | JP 81 | 86.86 |
| Tumors and Oncological Cases | 2021-2025 | 212 | JP 8 | 82.74 |
| Salivary Gland Tumors Diagnosis and Treatment | 2021-2025 | 579 | JP 38 | 80.57 |
| Cardiac tumors and thrombi | 2021-2025 | 670 | JP 70 | 72.68 |
| Vascular Tumors and Angiosarcomas | 2021-2025 | 603 | JP 58 | 63.32 |
